Portrait of Lawrence, Brenda Lulenar

Lawrence, Brenda Lulenar

U.S. Representative MI-14 Democratic Party

Congressional stock trade history disclosed under the STOCK Act, as filed.

Disclosed trades
22
Buys / sells
73% / 27%
Last trade
Aug 12, 2019
Last filing
Aug 21, 2019

Latest disclosed trades

Latest 10 of 22
Ticker Type Traded
UBER Buy Aug 12, 2019
NVDA Buy May 14, 2019
UAA Buy May 14, 2019
F Buy May 10, 2019
NIO Buy Mar 14, 2019
CGC Buy Oct 23, 2018
AMZN Buy Oct 11, 2018
AMD Buy Sep 10, 2018
SURG Buy Jul 12, 2018
GIS Sell May 14, 2018

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window.

Lawrence, Brenda Lulenar stock trade activity

FilingIQ has indexed 22 congressional stock trade disclosures for Lawrence, Brenda Lulenar. The most recent disclosed transaction is dated Aug 12, 2019.

Across the full history, 16 purchases and 6 sales have been disclosed under the STOCK Act.

Top tickers traded by Lawrence, Brenda Lulenar

Frequently asked

How many stock trades has Lawrence, Brenda Lulenar disclosed?
FilingIQ tracks 22 Periodic Transaction Report disclosures for Lawrence, Brenda Lulenar, with the most recent dated Aug 12, 2019. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Lawrence, Brenda Lulenar a net buyer or net seller?
Across the disclosed trade history, 16 (73%) were purchases and 6 (27%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Lawrence, Brenda Lulenar come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.